Foxp3 and IL-10 Expression Correlates with Parasite Burden in Lesional Tissues of Post Kala Azar Dermal Leishmaniasis (PKDL) Patients
Figure 3
Immunohistochemical analysis of Foxp3 in tissue lesions of PKDL patients.
Distribution of Foxp3 in dermal lesion tissue sections at pre treatment, post treatment stages and normal skin of healthy individuals. Panel A (10×), Panel B (40×) magnification.